Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia

Acta Dermato-Venereologica

Volumn 79, Issue 2, 1999, Pages 118-121

  Yosipovitch, Gil ^a   Maibach, Howard I ^b   Rowbotham, Michael C ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heat hyperalgesia; Thermal testing; Thermal thresholds

Indexed keywords

CAPSAICIN; EMLA;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CHEMICAL BURN; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAT TOLERANCE; HUMAN; HYPERALGESIA; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; PRURITUS;

EID: 0032968111     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750011327     Document Type: Article

References (17)

1. Rains C, Bryson HM. Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drug Aging 1995; 7: 317-328.
2. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin a multicenter, double-blind, vehicle- controlled study. Arch Intern Med 1991; 151: 2225-2229.
3. Breneman DL, Cardone S, Blumsack RF, Lather RM, Searle EA, Pollack VE. Topical capsaicin for treatment of hemodialysis related pruritus. J Am Acad Dermatol 1992; 26: 91-94.
4. Lynn B. Capsaicin actions on C fibre afferents that may be involved in itch. Skin Pharmacol 1992; 5: 9-13.
5. Bernstein J. Capsaicin in dermatologic disease. Semin Dermatol 1988; 7: 304-309.
6. Watson CPN, Evans RJ, Watt VR. Post herpetic neuralgia and topical capsaicin. Pain 1988; 33: 333-340.
7. Yosipovitch G, Yarnitsky D. Quantitative sensory testing, In: Marzulli FN, Maibach HI, eds, Dermatotoxicology methods. Taylor & Francis, Bristol, PA 1998; 313-317.
8. Rumsfield JA, West D. Topical capsaicin in dermatologic and peripheral pain disorders. DICP Ann Pharmacother 1991; 25: 381-387.
9. Carpenter SE, Lynn B. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin. Br J Pharmacol 1981; 73: 755-758.
10. Simone DA, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 1991; 47: 285-294.
11. 1 channels: local anaesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol Sci 1987; 8: 57-65.
12. Devor M, Wall P, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992; 48: 261-268.
13. Winter J, Bevan S, Campbell EA, Capsaicin and pain mechanisms. Br J Anaesth 1995; 75: 157-168.
14. Wallengren J, Hâkanson R. Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin. Br J Dermatol 1992; 126: 111-117.
15. Craft RM, Porreca F. Tetracaine attenuates irritancy without attenuating desensitization produced by intravesical resiniferatoxin in the rat. Pain 1994; 57: 351-359.
16. Walker F, Lewis S. Somesthetic and electrophysiologic effects of topical 0.025% capsaicin in man. Reg Anesth 1990; 15: 61-66.
17. Bjerring P, Arendt-Nielsen L. A quantitative comparison of the effect of local analgesics on argon laser induced cutaneous pain and on histamine induced wheal, flare and itch. Acta Derm Venereol (Stockh) 1990; 70: 126-131.